Table 2.
Number | Author, Year | Total Sample Size | Propranolol (n) | Comparison (n) | Type of CNS Effect | Number Patients with CNS Effect in | |
---|---|---|---|---|---|---|---|
Propranolol Group | Control Group | ||||||
1 | Abrazua-Araya, 2014 | 25 | 10 | 13 | Adverse event related to CNS | 0 | 0 |
2 | Kim, 2017 | 35 | 17 | 16 | Growth disability | 0 | 2 |
3 | Leaute-Labreze, 2013 | 16 | 7 | 7 | Drowsiness | 1 | 0 |
4 | Malik, 2013 | 22 | 10 | 10 | Somnolence | 1 | 0 |
5 | Gong, 2015 | 28 | 13 | 13 | Lethargy | 2 | 0 |
6 | Bauman, 2014 | 21 | 11 | 8 | Growth and development | 0 | 8 |
7 | Hogeling, 2011 | 39 | 19 | 20 | Sleep disturbances | 2 | 2 |
8 | Leaute-Labreze, 2015 | 456 | 401 | 55 | Sleep disorder | 83 | 7 |
456 | 401 | 55 | Agitation | 45 | 6 | ||
456 | 401 | 55 | Somnolence | 12 | 1 | ||
9 | Tan, M., 2012 | 69 | 33 | 36 | Adverse event related to CNS | 0 | 0 |
10 | Zhong S, 2015 | 42 | 21 | 21 | Adverse event related to CNS | 0 | 0 |
11 | Jin, YJ, 2011 | 75 | 43 | 32 | Adverse event related to CNS | 0 | 0 |